Texas Children’s CORBEVAX COVID-19 Vaccine receives Emergency Use Authorization

Texas Children’s and Baylor College of Medicine announced on December 28, that CORBEVAX, a protein sub-unit COVID-19 Vaccine, whose technology was created and engineered at its Center for Vaccine Development (CVD), has received Emergency Use Authorization (EUA) approval from the Drugs Controller General of India (DCGI) to launch first in India, with other underserved countries to follow.